China
Are the US and China really in an AI “race”?
On July 16, the Engelberg Center for Health Care Reform at Brookings hosted the second annual State of Biomedical Innovation conference. The goal of this conference was to assess U.S. biomedical innovation and discuss policy solutions that ensure the nation remains a world leader. This year, the conference featured an update to last year’s discussion of the drivers of innovation and how best to track them through use of comprehensive metrics. In addition, the conference specifically focused on novel sources and applications of big data in innovation, with senior-level thought leaders from government, academia, industry, patient advocacy, and clinical care present to share their views and recommendations.
Agenda
-
July 16
-
Innovation in Action
10:10 am
GEGabriel Eichler General Manager, Client Services & Strategic Initiatives - PatientsLikeMeDGDalvir Gill Chief Executive Officer - TransCelerate BioPharma Inc.MKMartin Kohn Chief Medical Scientist, Care Delivery Systems - Watson Research Center, IBMJMTJeffrey M. Trent President and Research Director - Translational Genomics Research Institute -
Establishing Baseline Metrics in Biomedical Innovation
11:25 am
MAMurray Aitken Senior Vice President - IMS HealthKKKen Kaitin Director, Tufts Center for the Study of Drug Development, and Professor - Tufts University School of MedicineJLJonathan Leff Partner - Deerfield ManagementBMBernard Munos Founder - InnoThink Center for Research in Biomedical Innovation -
Creating Novel Sources and Applications of Data through Policy
9:15 am
JWJanet Woodcock Director, Center for Drug Evaluation and Research - US Food and Drug AdministrationKHKathy Hudson Deputy Director for Science, Outreach, and Policy - National Institutes of HealthBLBryan Luce -
Break
11:10 am
JWJanet Woodcock Director, Center for Drug Evaluation and Research - US Food and Drug AdministrationKHKathy Hudson Deputy Director for Science, Outreach, and Policy - National Institutes of HealthBLBryan Luce
-
